Dr. Amin on Evaluating Response to Immunotherapy in RCC

Dr. Amin on Evaluating Response to Immunotherapy in RCC

Dr. Amin on Rationale for CheckMate-214 Trial in RCCПодробнее

Dr. Amin on Rationale for CheckMate-214 Trial in RCC

Dr. Amin on Toxicities With Immunotherapy/TKI Combinations in RCCПодробнее

Dr. Amin on Toxicities With Immunotherapy/TKI Combinations in RCC

Dr. Albiges on Next Steps for Immunotherapy in RCCПодробнее

Dr. Albiges on Next Steps for Immunotherapy in RCC

Evaluating I-O Monotherapy’s Value in Treating mRCCПодробнее

Evaluating I-O Monotherapy’s Value in Treating mRCC

Nephrectomy after complete response to immune checkpoint inhibitors for mRCCПодробнее

Nephrectomy after complete response to immune checkpoint inhibitors for mRCC

Dr. Choueiri on Using Immunotherapy to Treat RCCПодробнее

Dr. Choueiri on Using Immunotherapy to Treat RCC

Use of Immunotherapy in RCC Asim Amin, M.D., PhD.Подробнее

Use of Immunotherapy in RCC Asim Amin, M.D., PhD.

Dr. Amin on Next Steps With Immunotherapy in Advanced RCCПодробнее

Dr. Amin on Next Steps With Immunotherapy in Advanced RCC

Understanding and Working With New Immunotherapeutic and Targeted Management Models in Advanced RCCПодробнее

Understanding and Working With New Immunotherapeutic and Targeted Management Models in Advanced RCC

Importance of Risk Assessment in Renal Cell CarcinomaПодробнее

Importance of Risk Assessment in Renal Cell Carcinoma

Dr. Choueiri on Ongoing Trials of Immunotherapy in RCCПодробнее

Dr. Choueiri on Ongoing Trials of Immunotherapy in RCC

Dr. Jonasch on the Potential of Immunotherapy for Sarcomatoid RCCПодробнее

Dr. Jonasch on the Potential of Immunotherapy for Sarcomatoid RCC

Dr. Kim on Combining Immunotherapy and TKIs in Metastatic RCCПодробнее

Dr. Kim on Combining Immunotherapy and TKIs in Metastatic RCC

Immunotherapy in Renal Cell CarcinomaПодробнее

Immunotherapy in Renal Cell Carcinoma

Dr. McDermott on Novel Immunotherapy Combinations in RCCПодробнее

Dr. McDermott on Novel Immunotherapy Combinations in RCC

Dr. Rini on Adjuvant Immunotherapy in Renal Cell CarcinomaПодробнее

Dr. Rini on Adjuvant Immunotherapy in Renal Cell Carcinoma

How do you evaluate patients' response to immunotherapy?Подробнее

How do you evaluate patients' response to immunotherapy?

Updated Results of a Clinical Trial Evaluating Pembrolizumab + Axitinib for Frontline Adv RCCПодробнее

Updated Results of a Clinical Trial Evaluating Pembrolizumab + Axitinib for Frontline Adv RCC

Dr. Rini Discusses Tivozanib in Advanced RCCПодробнее

Dr. Rini Discusses Tivozanib in Advanced RCC